“…A wide range of compounds that contain in their structure the dibenzosuberone unit formed by two aromatic rings fused with a seven-atom cycle have been proven effective for the treatment of depressive disorders, nowadays a highly prevalent illness, as well as for a variety of painful conditions: migraine headache, noncardiac chest pain, functional dyspepsia and irritable bowel syndrome (IBS) [ 1 , 2 , 3 , 4 , 5 ]. Tricyclic antidepressants (TCAs) containing dibenzosuberone moieties mostly affect the autonomic and central nervous systems, and traditional cyclic antidepressants, like amitriptyline ( 4 ) [ 6 , 7 , 8 ], imipramine ( 5 ) [ 9 ] and noxiptiline ( 6 ) [ 10 , 11 ] continue to be used as first-line agents in treating depressive disorders and an expanding list of additional conditions [ 12 , 13 , 14 , 15 ], with amitriptyline being the most commonly prescribed TCA.
…”